Search results
Shining light on sepsis: Novel device could allow early detection of deadly condition
Medical Xpress· 6 days agoThe doctor can then treat the patient, often with antibiotics and intravenous fluids, to try to...
...of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical...
Morningstar· 3 days agoNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 5 days agoU.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE PR Newswire TOKYO, May 30, 2024 If approved, the investigational ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoInnovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting ...
Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine...
The Grass Valley Union· 4 days agoIonis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive results from the Phase 3 OASIS-HAE and OASISplus studies of donidalorsen in patients with hereditary angioedema (HAE) demonstrating significant and sustained reduction in mean monthly HAE attack rates and continued attack rate...
An economic and political blunder?
BusinessWorld· 2 days agoThe administration is seeking to amend the Rice Tariffication Law to address the high price of rice and President Ferdinand “Bongbong” Marcos, Jr.’s declining ...
IU Northwest names Vicki Roman-Lagunas as interim chancellor
The Times of Northwest Indiana· 3 days agoVicki Roman-Lagunas will succeed Chancellor Ken Iwama as IU Northwest's interim chancellor,...